1. Mitochondrial cardioencephalopathy due to a COQ4 mutation
    Josef Finsterer et al, 2017, Molecular Genetics and Metabolism Reports CrossRef
  2. Late-onset MELAS with Chronic Kidney Disease
    Il-yeon Choo et al, 2017, J Korean Neurol Assoc CrossRef
  3. Low Heteroplasmy Rates of the m.8993T>G Variant May Not Be Pathogenic
    Josef Finsterer et al, 2018, American Journal of Kidney Diseases CrossRef
  4. Congenital sideroblastic anemia: Advances in gene mutations and pathophysiology
    Zhangbiao Long et al, 2018, Gene CrossRef
  5. Legionella Pneumonia Complicated with Acquired Fanconi Syndrome: A Case Report
    Ryo Koda et al, 2018, Intern. Med. CrossRef
  6. Nephrological and urological complications of homozygous c.974G>A (p.Arg325Gln) OSGEP mutations
    Peter Zhan Tao Wang et al, 2018, Pediatr Nephrol CrossRef
  7. Clinical, Neuroimaging, and Pathological Analyses of 13 Chinese Leigh Syndrome Patients with Mitochondrial DNA Mutations
    Xiao-Lin Yu et al, 2018, Chinese Medical Journal CrossRef
  8. Mitochondrial Disease (MELAS Syndrome) Discovered at the Start of Pregnancy in a Patient with Advanced CKD: A Clinical and Ethical Challenge
    Domenico Santoro et al, 2019, JCM CrossRef
  9. Nephrotic syndrome and mitochondrial disorders: answers
    Julie Bernardor et al, 2019, Pediatr Nephrol CrossRef
  10. The footprints of mitochondrial impairment and cellular energy crisis in the pathogenesis of xenobiotics-induced nephrotoxicity, serum electrolytes imbalance, and Fanconi’s syndrome: A comprehensive review
    Reza Heidari, 2019, Toxicology CrossRef
  11. Cerebral imaging in adult mitochondrial disorders
    Josef Finsterer, 2019, Journal of the Neurological Sciences CrossRef
  12. Characterization of the renal phenotype in RMND1 ‐related mitochondrial disease
    Brian J. Shayota et al, 2019, Mol Genet Genomic Med CrossRef
  13. Exome Sequencing and Metabolomic Analysis of A Chronic Kidney Disease and Hearing Loss Patient Family Revealed RMND1 Mutation Induced Sphingolipid Metabolism Defects
    Nagwa Gaboon et al, 2019, Saudi Journal of Biological Sciences CrossRef
  14. Molecular genetic investigations identify new clinical phenotypes associated with BCS1L-related mitochondrial disease
    Monika Oláhová et al, 2019 CrossRef
  15. Adult onset tubulo‐interstitial nephropathy in MT‐ND5‐related phenotypes
    Hugo Bakis et al, 2020, Clin Genet CrossRef
  16. The Vicious Cycle of Renal Lipotoxicity and Mitochondrial Dysfunction
    Mengyuan Ge et al, 2020, Front. Physiol. CrossRef
  17. Agmatine alleviates hepatic and renal injury in a rat model of obstructive jaundice
    Mohammad Mehdi Ommati et al, 2020, PharmaNutrition CrossRef
  18. null
    Andreas M. Grabrucker, 2020 CrossRef
  19. Molecular characteristics and physiological roles of Na + –K + –Cl − cotransporter 2
    Andree‐Anne Marcoux et al, 2020, J Cell Physiol CrossRef
  20. Delayed diagnoses of mitochondrial cytopathies in patients presenting with end stage kidney disease: two case reports
    Tayeba Roper et al, 2020, BMC Nephrol CrossRef
  21. Mitochondrial disease and the kidney with a special focus on CoQ10 deficiency
    Anne M. Schijvens et al, 2020, Kidney International Reports CrossRef
  22. The role of novel COQ8B mutations in glomerulopathy and related kidney defects
    Asmaa S. AbuMaziad et al, 2020, Am J Med Genet CrossRef
  23. Kidney epithelial targeted mitochondrial transcription factor A deficiency results in progressive mitochondrial depletion associated with severe cystic disease.
    Ken Ishii et al, 2020, Kidney International CrossRef
  24. Apoptosis-inducing factor plays a role in the pathogenesis of hepatic and renal injury during cholestasis
    Vahid Ghanbarinejad et al, 2021, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
  25. m.3243A>G carriers develop syndromic or non-syndromic multisystem phenotypes over time
    J. Finsterer, 2021, CEN Case Rep CrossRef
  26. Authors’ reply to “m.3243A>G carriers develop syndromic or non-syndromic multisystem phenotypes over time”
    Kenta Tanaka et al, 2021, CEN Case Rep CrossRef
  27. Exome sequencing identifies a disease variant of the mitochondrial ATP‐Mg/Pi carrier SLC25A25 in two families with kidney stones
    M. Reza Jabalameli et al, 2021, Mol Genet Genomic Med CrossRef
  28. Novel variants in OSGEP leading to Galloway-Mowat syndrome by altering its subcellular localization
    Hua Teng et al, 2021, Clinica Chimica Acta CrossRef
  29. Fanconi syndrome, nephrotic-range proteinuria, and hypoalbuminemia in a newborn—Occam’s razor or Hickam’s dictum? Answers
    James T. Nugent et al, 2022, Pediatr Nephrol CrossRef
  30. null
    Lovelesh K. Nigam et al, 2022 CrossRef
  31. A case report of mitochondrial myopathy with membranous nephropathy
    Minchao Cai et al, 2022, BMC Nephrol CrossRef
  32. Disruption of mitochondrial complex III in cap mesenchyme but not in ureteric progenitors results in defective nephrogenesis associated with amino acid deficiency
    Nan Guan et al, 2022, Kidney International CrossRef
  33. The Spectrum of Renal Abnormalities in Mitochondrial Disorders Is Broad
    Josef Finsterer, 2022, Kidney International Reports CrossRef
  34. Case Report: Optic Atrophy and Nephropathy With m.13513G>A/MT-ND5 mtDNA Pathogenic Variant
    Valentina Barone et al, 2022, Front. Genet. CrossRef
  35. Recent advances in mitochondrial diseases: From molecular insights to therapeutic perspectives
    Ahmad M. Aldossary et al, 2022, Saudi Pharmaceutical Journal CrossRef
  36. Galloway–Mowat Syndrome Type 3 Caused by OSGEP Gene Variants: A Case Report and Literature Review
    Suhua Xu et al, 2022, Front. Pediatr. CrossRef
  37. Increased Peripheral Blood Heteroplasmy of the mt.3243A>G Mutation Is Associated with Earlier End-Stage Kidney Disease: A Case Report and Review of the Literature
    James A.D. Shand et al, 2020, Nephron CrossRef
  38. Modeling SILAC Data to Assess Protein Turnover in a Cellular Model of Diabetic Nephropathy
    Barbara Di Camillo et al, 2023, IJMS CrossRef
  39. Cardiac Involvement in Mitochondrial Disorders
    Tudor-Alexandru Popoiu et al, 2023, Curr Heart Fail Rep CrossRef
  40. Effects of Antioxidant Combinations on the Renal Toxicity Induced Rats by Gold Nanoparticles
    Ghedeir M. Alshammari et al, 2023, Molecules CrossRef
  41. Renal manifestations in adults with mitochondrial disease from the mtDNA m.3243A>G pathogenic variant
    Filipa Ferreira et al, 2023, Nefrología CrossRef
  42. Kidney-Related Function of Mitochondrial Protein Mitoregulin
    Olga A. Averina et al, 2023, IJMS CrossRef
  43. Vitamin A and retinoid signaling in the kidneys
    Krysta DiKun et al, 2023, Pharmacology & Therapeutics CrossRef
  44. Case report: Birk–Landau–Perez syndrome linked to the SLC30A9 gene—identification of additional cases and expansion of the phenotypic spectrum
    Praseetha Kizhakkedath et al, 2023, Front. Genet. CrossRef
  45. Severe Antenatal Hypertrophic Cardiomyopathy Secondary to ACAD9-Related Mitochondrial Complex I Deficiency
    Charlotte Dubucs et al, 2023, Mol Syndromol CrossRef
  46. Mitochondrial Chronic Progressive External Ophthalmoplegia
    Ali Ali et al, 2024, Brain Sciences CrossRef
  47. Retinoic acid receptor α activity in proximal tubules prevents kidney injury and fibrosis
    Krysta M. DiKun et al, 2024, Proc. Natl. Acad. Sci. U.S.A. CrossRef
  48. Renal manifestations in adults with mitochondrial disease from the mtDNA m.3243A>G pathogenic variant
    Filipa Ferreira et al, 2023, Nefrología (English Edition) CrossRef
  49. Expanding the Phenotypic Spectrum: Chronic Kidney Disease in a Patient with Combined Oxidative Phosphorylation Defect 21
    A Paripović et al, 2023 CrossRef
  50. Review of childhood genetic nephrolithiasis and nephrocalcinosis
    Ashley M. Gefen et al, 2024, Front. Genet. CrossRef
  51. Mitochondrial DNA 13513G>A Mutation Causing Leber Hereditary Optic Neuropathy Associated With Adult-Onset Renal Failure
    Grace Swart et al, 2024 CrossRef